Memed Sp. z o.o. (Poland)

Main Activities: General Medical and Surgical Hospitals

Secondary Activities: Pharmacies and Drug Stores | Advertising, Public Relations, and Related Services | Marketing Research and Public Opinion Polling | Ambulatory Health Care Services | Offices of Dentists

Full name: Memed Sp. z o.o.

Profile Updated: September 25, 2025

Memed Sp. z o.o. is an enterprise in Poland, with the main office in Lodz. The company operates in the General Medical and Surgical Hospitals industry. It was first established on May 28, 2021. There was a net sales revenue increase of 643.73% reported in Memed Sp. z o.o.’s latest financial highlights for 2024. During that time, Memed Sp. z o.o.’s total assets grew by 667.1%.

Headquarters
Ul. Zielona 29
Lodz; Lodzkie; Postal Code: 90-602

Contact Details: Purchase the Memed Sp. z o.o. report to view the information.

Basic Information

Registered Capital:

Purchase the Memed Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Memed Sp. z o.o. report to view the information.

Incorporation Date:

May 28, 2021

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

90%

Purchase this report to view the information.

10%

Company Performance

Financial values in the chart are available after Memed Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

643.73%▲

Total operating revenue

643.73%▲

Operating profit (EBIT)

N/A

EBITDA

N/A

Net Profit (Loss) for the Period

N/A

Total Assets

667.1%▲

Total Equity

N/A

Operating Profit Margin (ROS)

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

-28.58%▼

Similar companies